World Health Organization (2023) Dementia. available at: https://www.who.int/news-room/fact-sheets/detail/dementia. (Accessed on January 2024)

Wang Y, Branicky R, Noë A, Hekimi S (2018) Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signalling. J Cell Biol 217:1915

Article  CAS  PubMed  PubMed Central  Google Scholar 

Conti Filho CE, Loss LB, Marcolongo-Pereira C, Junior Rossoni et al (2023) Advances in Alzheimer’s disease’s pharmacological treatment. Front Pharmacol 14:1101452

Article  PubMed  PubMed Central  Google Scholar 

Poudel P, Park S (2022) Recent advances in the treatment of Alzheimer’s disease using nanoparticle-based drug delivery systems. Pharmaceutics 14:835

Article  CAS  PubMed  PubMed Central  Google Scholar 

Prasansuklab A, Tencomnao T (2013) Amyloidosis in Alzheimer’s Disease: The Toxicity of Amyloid Beta (A β ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy. Evid Based Complement Alternat Med. 2013:413808. https://doi.org/10.1155/2013/413808

Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer’s disease: causes and treatment. Molecules 25:5789

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andersen E, Casteigne B, Chapman WD, Creed A, Foster F, Lapins A et al (2021) Diagnostic biomarkers in Alzheimer’s disease. Biomark Neuropsychiatr 5:100041

Article  Google Scholar 

King A, Bodi I, Troakes C (2020) The neuropathological diagnosis of Alzheimer’s disease—the challenges of pathological mimics and concomitant pathology. Brain Sci 10:1–23

Article  Google Scholar 

Shakir MN, Dugger BN (2022) Advances in deep neuropathological phenotyping of Alzheimer disease: past, present, and future. J Neuropathol Exp Neurol 81:2–15

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deture MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer’s disease. Mol Neurodegener 14:32

Article  PubMed  PubMed Central  Google Scholar 

Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT (2011) Neuropathological alterations in Alzheimer disease. Cold Spring Harbor Perspect Med 1:006189

Article  Google Scholar 

Kocahan S, Doǧan Z (2017) Mechanisms of Alzheimer’s disease pathogenesis and prevention: the brain, neural pathology, N-methyl-d-aspartate receptors, tau protein and other risk factors. Clin Psychopharmacol Neurosci 15:1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dorostkar MM, Zou C, Blazquez-Llorca L, Herms J (2015) Analysing dendritic spine pathology in Alzheimer’s disease: problems and opportunities. Acta Neuropathol 130:1–19

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen GF, Xu TH, Yan Y, Zhou YR, Jiang Y, Melcher K, Xu HE (2017) Amyloid beta: structure, biology and structure-based therapeutic development. Acta Pharmacol Sin 38:1205–1235

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ et al (2005) Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat Neurosci 8:79–84

Article  CAS  PubMed  Google Scholar 

von Bonhorst FP, Gall D, DuPont G (2022) Impact of β-amyloids induced disruption of Ca2+ homeostasis in a simple model of neuronal activity. Cells 11:615

Article  Google Scholar 

Wolfe MS, Li W, Trabocchi A (2021) Probing mechanisms and therapeutic potential of γ-secretase in Alzheimer’s disease. Molecules 26:388

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jeremic D, Jiménez-Díaz L, Navarro-López JD (2021) Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer’s disease: a systematic review. Ageing Res Rev 72:101496. https://doi.org/10.1016/J.ARR.2021.101496

Article  CAS  PubMed  Google Scholar 

Wagemann O, Liu H, Wang G, Shi X, Bittner T, Scelsi MA et al (2024) Dominantly inherited Alzheimer network–trials unit Downstream biomarker effects of gantenerumab or solanezumab in dominantly inherited Alzheimer disease: the DIAN-TU-001 randomized clinical trial. JAMA Neurol 81(6):582–93

Article  PubMed  PubMed Central  Google Scholar 

Medeiros R, Baglietto-Vargas D, Laferla FM (2011) The role of tau in Alzheimer’s disease and related disorders. CNS Neurosci Ther 17:514

Article  CAS  PubMed  Google Scholar 

Alquezar C, Arya S, Kao AW (2020) Tau posttranslational modifications: dynamic transformers of tau function, degradation, and aggregation. Front Neurol 11:595532

Article  PubMed  Google Scholar 

Guo T, Noble W, Hanger DP (2017) Roles of tau protein in health and disease. Acta Neuropathol 133:665

Article  CAS  PubMed  PubMed Central  Google Scholar 

McKibben KM, Rhoades E (2013) Independent tubulin binding and polymerization by the proline-rich region of tau is regulated by tau’s N-terminal domain. J Biol Chem 294:19381. https://doi.org/10.1074/JBC.RA119.010172

Article  Google Scholar 

Holper S, Watson R, Yassi N (2022) Tau as a biomarker of neurodegeneration. Int J Mol Sci 23(13):7307. https://doi.org/10.3390/IJMS23137307

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sayas CL, Ávila J (2021) GSK-3 and tau: a key duet in Alzheimer’s disease. Cells, 10(4). https://doi.org/10.3390/CELLS10040721

Sebastián-Serrano Á, De Diego-García L, Díaz-Hernández M (2018) The neurotoxic role of extracellular tau protein. Int J Mol Sci 19:998

Article  PubMed  PubMed Central  Google Scholar 

Nisa FY, Rahman MA, Hossen MA, Khan MF, Khan MAN, Majid M et al (2021) Role of neurotoxicants in the pathogenesis of Alzheimer’s disease: a mechanistic insight. Ann Med 53:1476. https://doi.org/10.1080/07853890.2021.1966088

Article  CAS  PubMed  Google Scholar 

Cheng H, Yang B, Ke T, Li S, Yang X, Aschner M, Chen P (2021) Mechanisms of metal-induced mitochondrial dysfunction in neurological disorders. Toxics 9:142

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayton S, Wang Y, Diouf I, Schneider JA, Brockman J, Morris MC, Bush AI (2020) Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology. Mol Psychiatry 25:2932. https://doi.org/10.1038/S41380-019-0375-7

Article  CAS  PubMed  Google Scholar 

Kenkhuis B, Somarakis A, de Haan L, Dzyubachyk O, Ijsselsteijn ME, de Miranda NF et al (2021) Iron loading is a prominent feature of activated microglia in Alzheimer’s disease patients. Acta Neuropathol Commun 9:1–15

Article  Google Scholar 

Tönnies E, Trushina E (2017) Oxidative stress, synaptic dysfunction, and Alzheimer’s disease. Journal of Alzheimer’s Disease 57:1105

Article  PubMed  PubMed Central  Google Scholar 

Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol 14:450

Article  CAS  PubMed  Google Scholar 

Ajoolabady A, Lindholm D, Ren J, Pratico D (2022) ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments. Cell Death Dis 13:1–15

Article  Google Scholar